1-20 of 22
Chiun-Sheng Huang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P1-04-02: Immune milieu associated with PD-L1 status in TNBC is dependent on time of biomarker assessment and treatment received: A secondary analysis of the NeoTRIPaPDL1 trial

Maurizio Callari, Chiun-Sheng Huang, Daniel Egle, Begoña Bermejo, Claudio Zamagni, Matteo Dugo, Marc Thill, Antonio Anton, Marco Barreca, Stefania Russo, Eva Maria Ciruelos, Richard Greil, Stefania Zambelli, Balázs Gyorffy, Chanel Smart, Olivia Biasi, Pinuccia Valagussa, Giuseppe Viale, Luca Gianni, Giampaolo Bianchini
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P1-04-02.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P1-04-02
Published: 15 February 2022
View article
Journal Articles

Abstract P2-07-12: Triple negative breast cancer subtypes and early dynamics of the 27-gene IO score predict pCR in the NeoTRIPaPDL1 trial

Matteo Dugo, Chiun-Sheng Huang, Daniel Egle, Begoña Bermejo, Claudio Zamagni, Robert S. Seitz, Tyler J. Nielsen, Marc Thill, Antonio Anton, Stefania Russo, Eva Maria Ciruelos, Brock L. Schweitzer, Douglas T. Ross, Barbara Galbardi, Richard Greil, Vladimir Semiglazov, Balázs Gyorffy, Marco Colleoni, Catherine Kelly, Gabriella Mariani, Lucia Del Mastro, Pinuccia Valagussa, Giuseppe Viale, Maurizio Callari, Luca Gianni, Giampaolo Bianchini
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P2-07-12.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P2-07-12
Published: 15 February 2022
View article
Journal Articles

Abstract P2-13-17: A phase III, randomized, multicenter, double-blind study to compare efficacy and safety of EG12014 (EirGenix trastuzumab) with Herceptin® as neoadjuvant treatment in combination with anthracycline/paclitaxel-based systemic therapy in patients with HER2-positive early breast cancer - a multinational phase III study conducted during the COVID-19 pandemic

Barbara Grohmann-Izay, Chiun-Sheng Huang, Giorgi Dzagnidze, Nestor Llinas, Anand Misra, Denys Pominchuk, Alexander Prokhorov, Bernardo Rapoport, Vladimir Semiglazov, Ling-Ming Tseng, Eduardo Yanez Ruiz, Sibylle Loibl
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P2-13-17.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-P2-13-17
Published: 15 February 2022
View article
Journal Articles

Abstract GS1-00: Single-cell spatial analysis by imaging mass cytometry and immunotherapy response in triple-negative breast cancer (TNBC) in the NeoTRIPaPDL1 trial

Giampaolo Bianchini, Xiao Qian Wang, Esther Danenberg, Chiun-Sheng Huang, Daniel Egle, Maurizio Callari, Begoña Bermejo, Claudio Zamagni, Marc Thill, Anton Anton, Matteo Dugo, Stefania Zambelli, Stefania Russo, Eva Maria Ciruelos, Richard Greil, Vladimir Semiglazov, Marco Colleoni, Catherine Kelly, Gabriella Mariani, Lucia Del Mastro, Balázs Győrffy, Olivia Biasi, Pinuccia Valagussa, Giuseppe Viale, Luca Gianni, H Raza Ali
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): GS1-00.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-GS1-00
Published: 15 February 2022
View article
Journal Articles

Abstract OT1-02-02: A global, phase 2 study of ARX788 in patients with HER2-positive metastatic breast cancer whose disease is resistant or refractory to T-DM1, and/or T-DXd, and/or tucatinib-containing regimens

Janice Lu, Kevin M Kalinsky, Debu Tripathy, George W Sledge, William Gradishar, Ruth O’Regan, Joyce O’Shaughnessy, Shanu Modi, Joshua Drago, Haeseong Park, Amelia McCartney, Sophia Frentzas, Catherine Shannon, Katharine Cuff, Richard Eek, Miguel Idzwan Martin, Giuseppe Curigliano, Guy Jerusalem, Chiun-Sheng Huang, Michael Press, Matt Li, Dong Xu, Cynthia Song, Richard Huhn, Jinchun Yan, Sara Hurvitz
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): OT1-02-02.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-OT1-02-02
Published: 15 February 2022
View article
Journal Articles

Abstract PD10-06: Predictive value of RT-qPCR 27-gene IO score and comparison with RNA-Seq IO score in the NeoTRIPaPDL1 trial

Matteo Dugo, Chiun-Sheng Huang, Daniel Egle, Begoña Bermejo, Claudio Zamagni, Robert S. Seitz, Tyler J. Nielsen, Marc Thill, Antonio Anton, Stefania Russo, Eva Maria Ciruelos, Brock L. Schweitzer, Douglas T. Ross, Barbara Galbardi, Richard Greil, Vladimir Semiglazov, Balázs Gyorffy, Marco Colleoni, Catherine Kelly, Gabriella Mariani, Lucia Del Mastro, Pinuccia Valagussa, Giuseppe Viale, Maurizio Callari, Luca Gianni, Giampaolo Bianchini
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): PD10-06.
DOI: https://doi.org/10.1158/1538-7445.SABCS21-PD10-06
Published: 15 February 2022
View article
Journal Articles

Abstract PS6-40: Clinical risk criteria and recurrence index for distant recurrence for patients with early stage luminal breast cancer

Skye Hung-Chun Cheng, Liang-Chih Liu, Ling-Ming Tseng, Chuan-Hsun Chang, Chiun-Sheng Huang, Ji-An Liang, Yu-Chen Hsu, Chia-Ming Hsieh, Jun-Ru Wei
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS6-40.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS6-40
Published: 15 February 2021
View article
Journal Articles

Abstract GS1-01: Primary outcome analysis of invasive disease-free survival for monarchE: abemaciclib combined with adjuvant endocrine therapy for high risk early breast cancer

Joyce A. O'Shaughnessy, Stephen Johnston, Nadia Harbeck, Masakazu Toi, Young-Hyuck Im, Mattea Reinisch, Zhimin Shao, Pirkko Liisa Kellokumpu Lehtinen, Chiun-Sheng Huang, Alexey Tryakin, Matthew Goetz, Hope S Rugo, Elzbieta Senkus, Laura Testa, Michael Andersson, Kenji Tamura, Guenther G. Steger, Lucia Del Mastro, Joanne Cox, Tammy Forrester, Sarah Sherwood, Xuelin Li, Ran Wei, Miguel Martin, Priya Rastogi
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): GS1-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-GS1-01
Published: 15 February 2021
View article
Journal Articles

Abstract OT-13-10: Global Phase 3 Study of Adagloxad Simolenin (OBI-822) and OBI-821 Versus Placebo Treatment for High Risk Early Stage Triple Negative Breast Cancer Patients (TNBC) Following Neoadjuvant or Adjuvant Chemotherapy

Hope Rugo, Louis W.C. Chow, Javier Cortes, Peter A. Fasching, Xu-Bing He, Pei Hsu, Chiun-Sheng Huang, Sung-Bae Kim, Yen-Shen Lu, Michelle Melisko, Rita Nanda, Tillman E Pearce, Priyanka Sharma, Richard Schwab
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): OT-13-10.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-OT-13-10
Published: 15 February 2021
View article
Journal Articles

Abstract PD12-06: Treatment-related amenorrhea with T-DM1 plus pertuzumab (KP) is lower than with docetaxel/carboplatin/trastuzumab/pertuzumab (TCHP) in the phase III neoadjuvant KRISTINE trial

Sara A Hurvitz, Rodrigo Fresco, Karen Afenjar, Daniil Stroyakovskiy, Chiun-Sheng Huang, Hans Wildiers, Kyung Hae Jung, Jean-François Boileau, Mario Campone, Miguel Martín, Vicente Valero, Joseph A. Sparano, W. Fraser Symmans, Peter A. Fasching, Alastair M. Thompson, Nadia Harbeck, Vanesa López-Valverde, Chunyan Song, Thomas Boulet, Eleonora Restuccia, Dennis J. Slamon
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PD12-06.
DOI: https://doi.org/10.1158/1538-7445.SABCS20-PD12-06
Published: 15 February 2021
View article
Journal Articles

Abstract 720: Analysis of circulating tumor DNA after neoadjuvant therapy to predict disease relapse in patients with stage II-III breast cancer

Po-Han Lin, Sung-Sheng Kuo, Chiun-Sheng Huang
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 720.
DOI: https://doi.org/10.1158/1538-7445.AM2020-720
Published: 15 August 2020
View article
Journal Articles

Abstract OT1-08-03: Phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of adagloxad simolenin (OBI-822) and OBI-821 treatment in patients with early-stage triple-negative breast cancer (TNBC) at high risk for recurrence

Hope S Rugo, Louis WC Chow, Javier Cortes, Peter A Fasching, Binghe Xu, Chiun-Sheng Huang, Sung-Bae Kim, Yen-Shen Lu, Rita Nanda, Priyanka Sharma, Richard B Schwab, Chen-En Tsai
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): OT1-08-03.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-OT1-08-03
Published: 15 February 2020
View article
Journal Articles

Abstract GS3-04: Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple negative, early high-risk and locally advanced breast cancer. NeoTRIPaPDL1 Michelangelo randomized study

Luca Gianni, Chiun-Sheng Huang, Daniel Egle, Begona Bermejo, Claudio Zamagni, Marc Thill, Antonio Anton, Stefania Zambelli, Giampaolo Bianchini, Stefania Russo, Eva Ciruelos, Richrad Greil, Vladimir Semiglazov, Marco Colleoni, Catherine Kelly, Gabriella Mariani, Lucia Del Mastro, Ilaria Maffeis, Pinuccia Valagussa, Giuseppe Viale
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): GS3-04.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-GS3-04
Published: 15 February 2020
View article
Journal Articles

Abstract P5-06-30: Identification of novel single nucleotide polymorphisms located in MAP3K1 and ABCB1 genes as markers for poor overall survival in early-stage hormone receptor-positive breast cancer using next-generation sequencing

Sung-Hsin Kuo, Shi-Yi Yang, Po-Han Lin, Chen-Hsin Chen, Hsin-Chou Yang, Chih-Yuan Hsu, Chiun-Sheng Huang
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P5-06-30.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-P5-06-30
Published: 15 February 2020
View article
Journal Articles

Abstract P3-14-01: Adjuvant trastuzumab emtansine (T-DM1) vs trastuzumab (H) in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: KATHERINE subgroup analysis

Max S Mano, Sibylle Loibl, Eleftherios P. Mamounas, Gunter von Minckwitz, Chiun-Sheng Huang, Michael Untch, Norman Wolmark, Irene L. Wapnir, Youngsen Yang, Alison K. Conlin, Sherko Kümmel, Mahasti Saghatchian, Michael P. DiGiovanna, Claudia Strunk, Martina Zimovjanova, Chunyan Song, Haying Liu, David Tesarowski, Steven Blotner, Lisa H. Lam, Melanie Smitt, Charles E. Geyer, Jr
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P3-14-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-P3-14-01
Published: 15 February 2020
View article
Journal Articles

Abstract 798: Label-free enrichment and detection of circulating tumor cells in metastatic breast cancer patients show 82% of cohorts have detectable targets

Yu-Jen Chang, Chen-Lin Chen, Wei-Fan Hsu, Meng-Ze Li, Wei-Yuan Ma, Ken-Chao Chen, Guan-Syuan Huang, Wai-Sang Wong, Jhan-Yu Syu, Thomas, Yo-Yan Huang, Ching-Hung Lin, Andrew M. Wo, Chiun-Sheng Huang
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 798.
DOI: https://doi.org/10.1158/1538-7445.AM2017-798
Published: 01 July 2017
View article
Journal Articles

Abstract 4490: Comparisons of genetic alterations of breast cancer between East and West: Special emphases on young patients with ER+/HER2- tumors

Ching-Hung Lin, Tzu-Pin Lu, Ruby Yun-Ju Huang, Yen-Shen Lu, Ko-Yun Lo, Kuan-Ting Kuo, Eric Y. Chuang, Pei-Fang Wu, I-Chun Chen, Jean Paul Thiery, Chiun-Sheng Huang, Ann-Lii Cheng
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4490.
DOI: https://doi.org/10.1158/1538-7445.AM2016-4490
Published: 15 July 2016
View article
Journal Articles

Abstract P5-19-01: Randomized Phase III trial of afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one prior trastuzumab treatment: LUX-Breast 1

Nadia Harbeck, Chiun-Sheng Huang, Sara Hurvitz, Dah-Cherng Yeh, Zhimin Shao, Seock-Ah Im, Kyung Hae Jung, Kunwei Shen, Jungsil Ro, Jacek Jassem, Qingyuan Zhang, Young-Hyuck Im, Marek Wojtukiewicz, Qiang Sun, Shin-Cheh Chen, Rainer-Georg Goeldner, Annick Lahogue, Martina Uttenreuther-Fischer, Binghe Xu, Martine Piccart-Gebhart, on Behalf of the LUX-Breast 1 Study Group
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P5-19-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS14-P5-19-01
Published: 01 May 2015
View article
Journal Articles

Abstract LB-262: Mesenchymal stem cell-like characteristics of human phyllodes tumors

Jin-Jin Lin, John Yu, Chiun-Sheng Huang, Kun-Tu Yeh, Huang-Chun Lien, Fen-Pi Chou, Wea-ying Chang, Alice L. Yu
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): LB-262.
DOI: https://doi.org/10.1158/1538-7445.AM10-LB-262
Published: 15 April 2010
View article
Journal Articles

Association between differential expression of metastasis-associated genes and axillary lymph node metastasis in breast cancer

Chun-Wen Cheng, Chiun-Sheng Huang, Chen-Yang Shen
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 256.
Published: 01 April 2004
View article